← Back to search

Erasca

Fuck cancer. Every year in the United States, nearly 1.75 million new cases of cancer are diagnosed and over 600,000 suc...

a16zPublic

What they do

Problem

Cancer causes high mortality and many patients lack effective targeted treatment options.

Solution

Erasca develops precision oncology therapies targeting cancer-driving molecular pathways.

Who it's for

Oncologists and cancer patients treated through hospitals and cancer centers.

Company timeline

Similar startups

SFA Therapeutics
Regulating the immune system to block cancer & autoimmune diseases
Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
BridgeBio
BridgeBio develops breakthrough medicines for genetic diseases. Its p…
Pharming Group
Pharming GroupA global biopharmaceutical company developing and comme…
Altay Therapeutics
Altay develops disease-modifying therapies targeting transcription…
Alpha-9 Oncology
Clinical-stage radiopharma pipeline of peptide-based, best-in-class o…